StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
168
This month
4
This week
2
This year
23
Today
1
Yesterday
2
Publishing Date
2024 - 01 - 17
3
2024 - 01 - 16
2
2024 - 01 - 09
2
2023 - 12 - 01
2
2023 - 11 - 28
2
2023 - 11 - 09
2
2023 - 11 - 03
2
2023 - 10 - 04
2
2023 - 10 - 03
4
2023 - 09 - 18
2
2023 - 09 - 11
3
2023 - 08 - 25
2
2023 - 03 - 31
2
2023 - 03 - 16
3
2023 - 02 - 20
2
2023 - 02 - 17
4
2023 - 02 - 08
2
2022 - 10 - 14
2
2022 - 09 - 29
2
2022 - 09 - 19
2
2022 - 06 - 27
2
2022 - 06 - 21
1
2022 - 06 - 17
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 27
1
2022 - 05 - 18
1
2022 - 05 - 11
1
2022 - 05 - 05
1
2022 - 05 - 04
1
2022 - 04 - 29
1
2022 - 04 - 25
1
2022 - 04 - 22
1
2022 - 04 - 14
1
2022 - 04 - 12
1
2022 - 04 - 11
1
2022 - 04 - 06
1
2022 - 03 - 25
4
2022 - 03 - 24
1
2022 - 03 - 22
1
2022 - 03 - 18
1
2022 - 03 - 15
1
2022 - 03 - 11
1
2022 - 01 - 21
1
2022 - 01 - 18
1
2022 - 01 - 13
1
2022 - 01 - 06
1
2022 - 01 - 04
1
2021 - 12 - 30
1
2021 - 12 - 22
3
2021 - 12 - 20
2
2021 - 12 - 17
1
2021 - 12 - 06
2
2021 - 11 - 11
1
2021 - 11 - 10
1
2021 - 11 - 04
1
2021 - 11 - 01
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 08
1
Sector
Commercial services
2
Consumer durables
1
Consumer non-durables
1
Electronic technology
7
Finance
1
Health care and social assistance
1
Health services
1
Health technology
168
Manufacturing
18
N/a
14
Process industries
3
Producer manufacturing
2
Professional, scientific, and technical services
1
Technology services
1
Tags
Acquire
2
Active
2
Agreement
4
Als
2
Alzheimer's
3
America
36
Application
5
Approval
8
Approved
2
Asia
4
Authorization
2
Bat2606
2
Biosimilar
21
Breast
2
Business
2
Cancer
12
Car-t
2
Chmp
10
Collaboration
2
Commercialization
2
Cosentyx
3
Disease
12
Drug
9
Ema
6
Europe
4
Fabhalta
3
Fda
19
Fda approval
3
Financial
4
First
3
For
4
Global
14
Growing
5
Growth
45
Health
3
Her2
3
Her2-
3
Immunotherapy
3
Jakavi
3
Kisqali
3
Leukemia
5
License
5
Market
72
Myeloid leukemia
3
N/a
156
Novartis
31
Patent
3
Pipeline
3
Positive
13
Report
16
Research
4
Results
7
Sclerosis
6
Solutions
5
Study
4
Therapeutics
18
Therapy
15
Treatment
22
Trial
3
Xolair
3
Entities
3m company
1
Abbott laboratories
13
Abbvie inc.
37
Abeona therapeutics inc.
2
Acadia pharmaceuticals inc.
1
Acelyrin, inc.
1
Adaptimmune therapeutics plc
2
Adt inc.
1
Advantest corp
1
Agilent technologies, inc.
1
Agios pharmaceuticals, inc.
1
Albemarle corporation
1
Alcon inc.
6
Alkermes plc
1
Allakos inc.
1
Alphabet inc.
1
Alvotech lux holdings s.a.s.
4
Amgen inc.
23
Anika therapeutics inc.
1
Apple inc.
2
Ashland global holdings inc.
1
Astellas pharma inc
11
Astrazeneca plc
25
Bausch health companies inc.
6
Baxter international inc.
9
Becton, dickinson and company
3
Beigene, ltd.
1
Biogen inc.
9
Biomarin pharmaceutical inc.
1
Biomx inc.
1
Biontech se
2
Boston scientific corporation
2
Brainstorm cell therapeutics inc.
1
Csl ltd
2
Denali therapeutics inc.
2
Eli lilly and company
10
Erasca inc
2
General electric company
3
Generation bio co.
2
Genmab a/s
6
Gilead sciences, inc.
2
Glaxosmithkline plc
39
Grifols sa
2
Incyte corporation
2
Johnson & johnson
25
Kamada ltd.
4
Lantheus holdings, inc.
2
Mallinckrodt plc
3
Medtronic plc
2
Meiragtx holdings plc
2
Morphosys ag
2
Novartis ag
168
Novo nordisk a/s
6
Orchard therapeutics plc
2
Pfizer, inc.
5
Sanofi
40
Takeda pharmaceutical company limited
2
Teva pharmaceutical industries ltd
36
Thermo fisher scientific inc
8
Viatris inc.
20
Symbols
AAPL
192
ABB
220
ABBV
235
ABLZF
207
ABT
288
AMGN
116
ARVL
725
AZN
119
BDX
122
BMO
187
BMY
186
BNPQF
150
BNPQY
150
CM
121
CSCO
202
CSSE
134
DSX
131
DUK
116
ERIC
276
FE
109
FNCTF
1250
GE
151
GILD
110
GOOG
140
GOOGL
142
GSK
144
HON
255
HUBS
220
INCY
154
INTC
183
IT
381
JNJ
816
LLY
410
LTUM
142
MDT
246
MMM
156
MRK
143
MS
466
MSFT
189
NVDA
130
NVS
200
NVSEF
168
ORCL
205
PCRFF
112
PCRFY
112
PFE
201
PHG
118
PPRUF
171
PPRUY
171
REGN
145
RY
139
SAP
256
SAPGF
228
SNOW
117
SNY
908
SNYNF
748
TAK
122
TEVJF
153
TMO
267
VZ
204
Exchanges
Amex
2
Nasdaq
168
Nyse
168
Crawled Date
2024 - 03 - 22
2
2024 - 01 - 17
3
2024 - 01 - 16
2
2024 - 01 - 09
2
2023 - 11 - 28
2
2023 - 11 - 09
2
2023 - 11 - 03
2
2023 - 10 - 04
2
2023 - 10 - 03
4
2023 - 09 - 18
2
2023 - 09 - 11
3
2023 - 08 - 25
2
2023 - 03 - 31
2
2023 - 03 - 16
3
2023 - 02 - 20
2
2023 - 02 - 17
4
2022 - 10 - 14
2
2022 - 09 - 29
2
2022 - 09 - 19
2
2022 - 06 - 27
2
2022 - 06 - 21
1
2022 - 06 - 17
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 27
1
2022 - 05 - 18
1
2022 - 05 - 11
1
2022 - 05 - 05
1
2022 - 05 - 04
1
2022 - 04 - 29
1
2022 - 04 - 25
1
2022 - 04 - 22
1
2022 - 04 - 14
1
2022 - 04 - 12
1
2022 - 04 - 11
1
2022 - 04 - 06
1
2022 - 03 - 25
4
2022 - 03 - 24
1
2022 - 03 - 22
1
2022 - 03 - 18
1
2022 - 03 - 15
1
2022 - 03 - 11
1
2022 - 01 - 21
1
2022 - 01 - 18
1
2022 - 01 - 13
1
2022 - 01 - 06
1
2022 - 01 - 04
1
2021 - 12 - 30
1
2021 - 12 - 23
1
2021 - 12 - 22
2
2021 - 12 - 20
2
2021 - 12 - 17
1
2021 - 12 - 06
2
2021 - 11 - 11
1
2021 - 11 - 10
1
2021 - 11 - 04
1
2021 - 11 - 01
1
2021 - 10 - 29
1
2021 - 10 - 25
1
2021 - 10 - 08
1
Crawled Time
00:00
4
00:20
1
01:00
6
02:00
5
03:00
10
04:00
2
05:00
7
06:00
15
07:00
7
08:00
8
09:00
9
10:00
3
11:00
5
12:00
8
12:20
4
12:30
3
13:00
7
13:30
1
14:00
5
14:20
1
15:00
5
15:20
3
16:00
6
17:00
7
18:00
7
19:00
7
20:00
4
21:00
4
22:00
7
23:00
7
Source
ir.voyagertherapeutics.com
1
www.biospace.com
12
www.globenewswire.com
62
www.prnewswire.com
93
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
for
symbols :
Nvsef
save search
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Published:
2024-04-24
(Crawled : 05:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.52%
|
O:
-0.36%
H:
0.05%
C:
-0.15%
malaria
positive
treatment
for
novartis
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Published:
2024-04-23
(Crawled : 18:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.94%
|
O:
1.69%
H:
0.02%
C:
-0.74%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
3.78%
|
O:
4.32%
H:
0.0%
C:
0.0%
lutathera
fda
first
approved
tumors
for
novartis
therapy
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.41%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
2.02%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.0%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
0.31%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
Published:
2024-03-22
(Crawled : 12:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.36%
|
O:
0.17%
H:
0.28%
C:
-0.01%
fabhalta
first
chmp
positive
novartis
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published:
2024-03-21
(Crawled : 00:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.36%
|
O:
0.17%
H:
0.28%
C:
-0.01%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-4.75%
|
O:
0.02%
H:
0.0%
C:
0.0%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-9.89%
|
O:
-0.74%
H:
1.54%
C:
1.38%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-5.0%
|
O:
0.16%
H:
0.0%
C:
0.0%
report
expansion
global
wellness
smart
growing
eye
market
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published:
2024-02-23
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-6.68%
|
O:
0.37%
H:
0.58%
C:
0.58%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-13.55%
|
O:
0.0%
H:
1.93%
C:
1.27%
NVO
|
News
|
$126.16
-1.93%
-0.23%
3.1M
|
Health Technology
|
1.32%
|
O:
-0.68%
H:
0.4%
C:
-0.18%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.33%
|
O:
0.89%
H:
0.4%
C:
0.17%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-7.67%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-0.98%
|
O:
0.97%
H:
0.0%
C:
0.0%
report
revenue
global
insulin
growth
market
Hydroxychloroquine Market to Reach $2.86 Billion by 2028 Amidst Rising Demand for Autoimmune Disease Treatments
Published:
2024-02-13
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
1.1%
|
O:
-2.71%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.72%
|
O:
-0.02%
H:
0.24%
C:
0.01%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.76%
|
O:
-1.1%
H:
0.0%
C:
0.0%
disease
reach
market
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published:
2024-02-07
(Crawled : 08:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
1.13%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-6.68%
|
O:
0.41%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-5.2%
|
O:
0.09%
H:
0.39%
C:
-0.36%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-2.13%
|
O:
0.43%
H:
0.67%
C:
0.21%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
3.07%
|
O:
0.21%
H:
0.24%
C:
-1.04%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-1.88%
|
O:
1.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.97%
|
O:
1.33%
H:
0.0%
C:
0.0%
BMRN
|
$91.25
-0.88%
-0.89%
1.6M
|
Health Technology
|
2.59%
|
O:
-0.38%
H:
1.79%
C:
0.22%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
6.21%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-13.62%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
america
therapeutics
growth
market
Novartis to strengthen oncology pipeline with agreement to acquire MorphoSys AG for EUR 68 per share or an aggregate of EUR 2.7bn in cash
Published:
2024-02-05
(Crawled : 22:00)
- globenewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-7.47%
|
O:
0.72%
H:
0.0%
C:
-1.56%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.95%
|
O:
-0.15%
H:
0.6%
C:
0.42%
MOR
|
News
|
$18.07
0.17%
0.17%
130K
|
Health Technology
|
4.52%
|
O:
1.39%
H:
0.34%
C:
-7.08%
pipeline
acquire
novartis
agreement
Global Sustained Release Coatings Markets, 2018-2022 and 2023-2028: Growing Demand for Controlled Drug Delivery Boosts Expansion
Published:
2024-02-01
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-3.39%
|
O:
-1.29%
H:
0.0%
C:
-1.38%
PFE
|
News
4
|
$26.27
-0.19%
-0.15%
23M
|
Health Technology
|
-2.99%
|
O:
0.07%
H:
0.83%
C:
0.7%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.95%
|
O:
1.55%
H:
0.79%
C:
0.25%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
3.6%
|
O:
1.27%
H:
1.87%
C:
1.73%
EMN
|
$96.36
-0.46%
0.0%
1.1M
|
Process Industries
|
15.33%
|
O:
0.79%
H:
0.8%
C:
0.77%
drug
expansion
global
growing
Antimicrobial Therapeutics Market to grow by USD 51.4 billion from 2022 to 2027, North America accounts for 38% of market growth- Technavio
Published:
2024-01-17
(Crawled : 06:00)
- prnewswire.com
CSLLY
|
$90.71
3.3%
35K
|
n/a
|
-3.79%
|
O:
-0.64%
H:
0.54%
C:
0.54%
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
1.33%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-9.53%
|
O:
-1.83%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-21.74%
|
O:
-1.74%
H:
0.0%
C:
-1.35%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.67%
|
O:
0.49%
H:
0.18%
C:
0.04%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
2.46%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
3.58%
|
O:
-0.15%
H:
0.74%
C:
0.18%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.18%
|
O:
0.45%
H:
0.06%
C:
-0.5%
america
therapeutics
market
Osteoarthritis Therapeutics Market to grow by USD 3.96 billion from 2022-2027, North America to account for 32% of market growth - Technavio
Published:
2024-01-17
(Crawled : 05:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
1.33%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-9.53%
|
O:
-1.83%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-1.7%
|
O:
-1.02%
H:
0.95%
C:
-1.46%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.67%
|
O:
0.49%
H:
0.18%
C:
0.04%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
2.46%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-5.81%
|
O:
0.12%
H:
0.77%
C:
0.27%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.18%
|
O:
0.45%
H:
0.06%
C:
-0.5%
ANIK
|
$26.02
0.89%
0.88%
31K
|
Health Technology
|
18.0%
|
O:
-1.05%
H:
3.55%
C:
3.31%
america
osteoarthritis
therapeutics
growth
market
Global Pseudomonas Aeruginosa Infection Treatment Market Report 2024-2034: Rising Antibiotic Resistance Drives Demand for Pseudomonas Aeruginosa Infection Treatments
Published:
2024-01-17
(Crawled : 02:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
1.33%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-9.53%
|
O:
-1.83%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.67%
|
O:
0.49%
H:
0.18%
C:
0.04%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-8.51%
|
O:
-1.02%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
2.46%
|
O:
-0.08%
H:
0.1%
C:
-0.18%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-5.81%
|
O:
0.12%
H:
0.77%
C:
0.27%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-8.18%
|
O:
0.45%
H:
0.06%
C:
-0.5%
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
-21.99%
|
O:
-0.19%
H:
0.87%
C:
0.76%
report
infection
treatment
global
market
Electron Microscope Market size to grow by USD 1.68 billion from 2022 to 2027; APAC to account for 55% of market growth- Technavio
Published:
2024-01-16
(Crawled : 09:00)
- prnewswire.com
ATEYY
|
$34.305
0.64%
2.1M
|
n/a
|
-0.63%
|
O:
1.01%
H:
2.93%
C:
2.47%
NINOY
|
$10.27
-3.3%
150K
|
Manufacturing
|
7.71%
|
O:
-0.2%
H:
0.0%
C:
-0.99%
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
5.19%
|
O:
-0.89%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.47%
|
O:
0.16%
H:
0.43%
C:
0.07%
KEYS
|
$146.6
-0.14%
0.0%
1.4M
|
Electronic Technology
|
-3.52%
|
O:
-0.78%
H:
0.42%
C:
-0.04%
market
Allergy Immunotherapies Market to grow by USD 1.01 billion from 2022 to 2027; Europe to account for 53% of market growth - Technavio
Published:
2024-01-16
(Crawled : 03:00)
- prnewswire.com
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
-1.11%
|
O:
-0.6%
H:
1.34%
C:
1.21%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.47%
|
O:
0.16%
H:
0.43%
C:
0.07%
europe
growth
market
Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA® (Lutetium Lu 177 Dotatate)
Published:
2024-01-11
(Crawled : 13:00)
- globenewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.46%
|
O:
-0.22%
H:
0.43%
C:
0.37%
LNTH
|
$65.19
1.21%
1.2%
580K
|
Health Technology
|
9.98%
|
O:
0.32%
H:
0.03%
C:
-4.42%
lutathera
Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published:
2024-01-09
(Crawled : 03:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-23.14%
|
O:
0.16%
H:
0.0%
C:
-3.88%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-9.65%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.88%
|
O:
-1.22%
H:
0.0%
C:
-0.72%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.15%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-7.93%
|
O:
0.74%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-12.18%
|
O:
-0.92%
H:
0.63%
C:
-0.25%
america
cancer
treatment
market
Contact Lens Solutions Market size to grow by USD 540.94 million from 2023 to 2028, Increased preference for contact lenses over spectacles to boost the market- Technavio
Published:
2024-01-09
(Crawled : 02:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-9.65%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.15%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
1.78%
|
O:
-0.48%
H:
6.87%
C:
-0.72%
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
|
2.87%
|
O:
-0.36%
H:
1.17%
C:
-0.52%
million
solutions
market
← Previous
1
2
3
4
5
6
7
8
9
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.